However, in the framework of the BC

However, in the framework of the BCS, biowaivers are restricted to APIs with high solubility across the physiological pH range, formulated in standard immediate release dosage forms (i.e. tablets or capsules), which is a relatively low-risk area of the biopharmaceutics space.

結果 (繁體中文) 1:

然而，在BCS的框架內，豁免生物等效研究僅限於與整個生理pH範圍內具有高的溶解度，在標準立即釋放劑型配製的API（即片劑或膠囊劑），其是生物藥劑學空間的相對低風險的區域。

結果 (繁體中文) 2:

然而，在BCS的框架內，生物豁免僅限於在生理pH範圍內具有高溶解度的API，以標準立即釋放劑型（即片劑或膠囊）配製，這是相對低風險的區域。生物製藥空間。

結果 (繁體中文) 3:

However，in the framework of the BCS，biowaivers are restricted to apis with high solubility across the physiological ph range，formulated in standard immediate release dossage forms（I.E.tablets or capsules），which is a relatively low-risk area of the biopharmaceut